Express | Subcutaneous RNAi Therapy Reached All Phase 3 Clinical Endpoints, New Drug Application Has Been Submitted
GM-CSF monoclonal antibody combined with Yescarta, all CRS events are less than or equal to grade 3!
Professor Kailin Xu: CAR-T has a good effect in treating ALL. Why does it relapse after treatment?
Experts from all parties call for the effectiveness of a multi-level medical security system
Nat Commun: 17 prospective studies reveal that blood n-3 fatty acid levels are associated with reduced all-cause mortality
Health Commission: 13 new confirmed cases, all imported from abroad
Health Commission: 6 newly confirmed cases on the 21st are all imported cases
Korea imports all kimchi in the first quarter of 2021 from China
Health Commission: 12 newly diagnosed cases on the 27th, all imported from abroad
Health Commission: The 20 newly diagnosed cases on the 28th were all imported from abroad
Health Commission: 11 new confirmed cases, all imported from abroad
Health Commission: 19 newly diagnosed cases on the 22nd, all imported from abroad
Have you found it! Supermarket goods are all "secretly reducing"! Chairman of the Food Association: This can reduce the obesity rate!
The number of all livestock species in Ukraine is declining
Health Commission: 9 new confirmed cases on the 23rd, all imported from abroad
All aspects of CD30 target: ADC is a hit, but red anti-double antibody has no fruit yet. CART research and development is fierce...
FAW Xiali becomes a loss-making company to mobilize all resources to bet on Junpai
All-round view of the CD30 target: ADC is a hit, but the red double antibody has no fruitful CAR...
Subcutaneous RNAi therapy has reached all phase 3 clinical endpoints and a new drug application has been submitted
[International] LANXESS released its financial situation in the third quarter, and all indexes have increased!